Stay updated on Nintedanib IPF Trial: Twice Daily vs Placebo
Sign up to get notified when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.

Latest updates to the Nintedanib IPF Trial: Twice Daily vs Placebo page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s supplementary resources section and related footer/disclaimer items were updated, and the interface/version label changed from an earlier revision to a newer one.SummaryDifference0.2%

- Check48 days agoChange DetectedRemoved the Genetic and Rare Diseases Information Center from Resources and removed the Interstitial lung disease 2 tag.SummaryDifference0.1%

- Check55 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; the update is visible in the footer and does not alter study details or page content.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check91 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2; this is a minor technical update and does not alter study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check98 days agoChange DetectedThe page shows a minor revision tag updated from v3.4.0 to v3.4.1, likely in the footer. This change does not alter study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nintedanib IPF Trial: Twice Daily vs Placebo
Enter your email address, and we'll notify you when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.